Literature DB >> 14532157

Signalling in osteoclasts and the role of Fos/AP1 proteins.

E F Wagner1, K Matsuo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14532157      PMCID： PMC1766737          DOI： 10.1136/ard.62.suppl_2.ii83

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  22 in total

1.  Impaired intervertebral disc formation in the absence of Jun.

Authors:  Axel Behrens; Jody Haigh; Fatima Mechta-Grigoriou; Andras Nagy; Moshe Yaniv; Erwin F Wagner
Journal:  Development       Date:  2003-01       Impact factor: 6.868

2.  Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Takako Koga; Hiroshi Nishina; Masashi Isshiki; Hiroki Yoshida; Akio Saiura; Miho Isobe; Taeko Yokochi; Jun-ichiro Inoue; Erwin F Wagner; Tak W Mak; Tatsuhiko Kodama; Tadatsugu Taniguchi
Journal:  Dev Cell       Date:  2002-12       Impact factor: 12.270

Review 3.  AP-1 as a regulator of cell life and death.

Authors:  Eitan Shaulian; Michael Karin
Journal:  Nat Cell Biol       Date:  2002-05       Impact factor: 28.824

4.  Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis.

Authors:  G Sabatakos; N A Sims; J Chen; K Aoki; M B Kelz; M Amling; Y Bouali; K Mukhopadhyay; K Ford; E J Nestler; R Baron
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

5.  Requirement for NF-kappaB in osteoclast and B-cell development.

Authors:  G Franzoso; L Carlson; L Xing; L Poljak; E W Shores; K D Brown; A Leonardi; T Tran; B F Boyce; U Siebenlist
Journal:  Genes Dev       Date:  1997-12-15       Impact factor: 11.361

6.  JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms.

Authors:  Jean-Pierre David; Kanaga Sabapathy; Oskar Hoffmann; Maria H Idarraga; Erwin F Wagner
Journal:  J Cell Sci       Date:  2002-11-15       Impact factor: 5.285

7.  Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2.

Authors:  V Iotsova; J Caamaño; J Loy; Y Yang; A Lewin; R Bravo
Journal:  Nat Med       Date:  1997-11       Impact factor: 53.440

8.  RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.

Authors:  Hiroshi Takayanagi; Sunhwa Kim; Koichi Matsuo; Hiroshi Suzuki; Tomohiko Suzuki; Kojiro Sato; Taeko Yokochi; Hiromi Oda; Kozo Nakamura; Nobutaka Ida; Erwin F Wagner; Tadatsugu Taniguchi
Journal:  Nature       Date:  2002-04-18       Impact factor: 49.962

9.  c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.

Authors:  A E Grigoriadis; Z Q Wang; M G Cecchini; W Hofstetter; R Felix; H A Fleisch; E F Wagner
Journal:  Science       Date:  1994-10-21       Impact factor: 47.728

10.  Osteoblasts are target cells for transformation in c-fos transgenic mice.

Authors:  A E Grigoriadis; K Schellander; Z Q Wang; E F Wagner
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539
View more
  19 in total

1.  Diacylglycerol Kinase ζ (DGKζ) Is a Critical Regulator of Bone Homeostasis Via Modulation of c-Fos Levels in Osteoclasts.

Authors:  Ali Zamani; Corinne Decker; Viviana Cremasco; Lindsey Hughes; Deborah V Novack; Roberta Faccio
Journal:  J Bone Miner Res       Date:  2015-08-26       Impact factor: 6.741

2.  The Nuclear Receptor AhR Controls Bone Homeostasis by Regulating Osteoclast Differentiation via the RANK/c-Fos Signaling Axis.

Authors:  Takashi Izawa; Rieko Arakaki; Hiroki Mori; Takaaki Tsunematsu; Yasusei Kudo; Eiji Tanaka; Naozumi Ishimaru
Journal:  J Immunol       Date:  2016-11-14       Impact factor: 5.422

3.  Effect of micro-osteoperforations on the gene expression profile of the periodontal ligament of orthodontically moved human teeth.

Authors:  Alice Spitz; Daniel Adesse; Michael Gonzalez; Renata Pellegrino; Hakon Hakonarson; Guido Artemio Marañón-Vásquez; Ana Maria Bolognese; Flavia Teles
Journal:  Clin Oral Investig       Date:  2021-09-09       Impact factor: 3.573

4.  Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.

Authors:  Kazunori Hamamura; Nancy Tanjung; Hiroki Yokota
Journal:  J Bone Miner Metab       Date:  2013-03-28       Impact factor: 2.626

5.  Predicting and validating the pathway of Wnt3a-driven suppression of osteoclastogenesis.

Authors:  Kazunori Hamamura; Andy Chen; Akinobu Nishimura; Nancy Tanjung; Akihiro Sudo; Hiroki Yokota
Journal:  Cell Signal       Date:  2014-07-16       Impact factor: 4.315

6.  SH3BP2 is an activator of NFAT activity and osteoclastogenesis.

Authors:  Steven A Lietman; Lihong Yin; Michael A Levine
Journal:  Biochem Biophys Res Commun       Date:  2008-04-25       Impact factor: 3.575

7.  Transforming growth factor-beta enables NFATc1 expression during osteoclastogenesis.

Authors:  S W Fox; K E Evans; A C Lovibond
Journal:  Biochem Biophys Res Commun       Date:  2007-12-03       Impact factor: 3.575

8.  Transcriptomic meta-analysis reveals up-regulation of gene expression functional in osteoclast differentiation in human septic shock.

Authors:  Samanwoy Mukhopadhyay; Pravat K Thatoi; Abhay D Pandey; Bidyut K Das; Balachandran Ravindran; Samsiddhi Bhattacharjee; Saroj K Mohapatra
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

Review 9.  Regulation of gene expression by microRNA in HCV infection and HCV-mediated hepatocellular carcinoma.

Authors:  Priyanka Gupta; Murray J Cairns; Nitin K Saksena
Journal:  Virol J       Date:  2014-04-01       Impact factor: 4.099

10.  Identification of DNA methylation changes associated with disease progression in subchondral bone with site-matched cartilage in knee osteoarthritis.

Authors:  Yanfei Zhang; Naoshi Fukui; Mitsunori Yahata; Yozo Katsuragawa; Toshiyuki Tashiro; Shiro Ikegawa; Ming Ta Michael Lee
Journal:  Sci Rep       Date:  2016-09-30       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.